Biolumina reposted this
🚨 New POV Drop: ASCO 2025 – A Cross-Network Take from Omnicom Health Omnicom Health showed up in full force at ASCO 2025, with attendees from across our network bringing a range of expertise—from science and strategy to access and engagement. In this latest thought leadership piece, we tapped into four of those voices, each offering a distinct perspective on the biggest conversations shaping oncology’s future: 🔬 Brenda Aske, RPh (Biolumina) – Precision science and brand storytelling 🤖 Steve Mason, Ph.D. (Healthcare Consultancy Group - HCG) – AI and trust in clinical decisions 🗣️ Aishah S. (TBWA\WORLDHEALTH) – Patient agency and equitable care 📈 John Hennessy (Valuate Health Consultancy) – Policy, access, and real-world impact Together, these reflections showcase the power of cross-network thinking—and how we’re living our belief: Uniquely Powerful, Together Unstoppable. 🔔 Want to stay in the know? Subscribe to The Next Big Thing: www.bethecasestudy.com #OmnicomHealth #ASCO2025 #ThoughtLeadership #OncologyMarketing #TogetherUnstoppable #TheNextBigThing #HealthcareStrategy #InnovationInOncology
